SURZELVIQ
Dead / Abandoned — Abandoned — failure to respond (as of 11 Mar 2022)
What this means for you
This application is over — abandoned 01 Mar 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90505245
- Mark type
- Stylized text
- Filed
- 02 Feb 2021
- Abandoned
- 01 Mar 2022
- Attorney of record
- Patrick J. Concannon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis
Owner
- Concert Pharmaceuticals, Inc., Lexington, MA, US
Prosecution history
- 11 Mar 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 11 Mar 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Aug 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Aug 2021 — NON-FINAL ACTION E-MAILED
- 27 Aug 2021 — NON-FINAL ACTION WRITTEN
- 23 Aug 2021 — ASSIGNED TO EXAMINER
- 05 May 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Feb 2021 — NEW APPLICATION ENTERED